Seoul, South Korea · Founded 2016 · Privately Held (backing)
Operator of a medical research firm intended to develop neuropathic treatments and diagnostic systems. Adel is based in Seoul, South Korea and was founded in 2016. It has raised $12.7 million.
Last price · $/share
—
Implied valuation
—
Total raised
$12.7M
Last round
—
Team — not yet on record
No current team members for Adel are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Adel with a free account
·The complete investor list: 17 names
·Watch Adel: the Monday email on marks, rounds and moves